Intellipharmaceutics International Inc. filed its Annual on Jun 05, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.94M | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt